Código QR (código de barras bidimensional)

Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials

BackgroundNon‐high‐density lipoprotein cholesterol (non‐HDL‐C) and apolipoprotein (apo) B are better predictors of atherosclerotic cardiovascular disease risk than low‐density lipoprotein cholesterol alone. US and European lipid management guidelines support non‐HDL‐C and apoB as targets for lipid‐l...

Fuld beskrivelse

Na minha lista:
Principais autores: Harold E. Bays, Lawrence A. Leiter, Helen M. Colhoun, Desmond Thompson, Laurence Bessac, Robert Pordy, Peter P. Toth
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2017-08-01
Serier:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Fag:
alirocumab
apolipoprotein B
cholesterol‐lowering
hypercholesterolemia
non‐high‐density lipoprotein cholesterol
PCSK9
Online adgang:https://www.ahajournals.org/doi/10.1161/JAHA.117.005639
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker